Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes – a tertiary care center experience - 18/05/22
, Bikram Choudhury a, Ankita Chugh b, Deepak Kumar c, Taruna Yadav d, Vidhi Jain e, Ashwini Agarwal e, Mayank Garg f, Kavita Bhatnagar g, Poonam Elhence h, Pradeep Kumar Bhatia i, Mahendra Kumar Garg c, Sanjeev Misra j
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Objective |
To evaluate the outcome of patients with ROCM (Rhino-orbito-cerebral mucormycosis) following their medical and surgical management.
Materials and methods |
It is a prognostic study based in a tertiary care center in North-Western India. Patients who developed ROCM post COVID-19 infection from 1st September 2020 to 30th June 2021 were included in this study. Surgical debridement and administration of antifungal therapy was done for the post-COVID-19 ROCM patients. Disease progression and survival was studied up to 5 months of follow-up in the second wave.
Results |
A total of 145 ROCM patients were included. The mean age at presentation, male: female ratio was 48.2 years and 2:1 respectively. As per our proposed new staging system and treatment strategy, the majority of patients belonged to stage II (31.72%) and stage III (31.03%). On a follow-up period of 5 months, 26 (18%) patients have lost their life and rest of the patients are on strict follow-up.
Conclusion |
ROCM is an extremely aggressive fungal infection which rapidly became an epidemic following the COVID-19 pandemic. The diverse and unique presentation led us to evolve a new strategy to classify and manage these patients.
El texto completo de este artículo está disponible en PDF.Keywords : ROCM (rhino-orbito-cerebral mucormycosis), COVID-19, Staging protocol, Outcome, Treatment, Amphotericin
Esquema
Vol 32 - N° 2
Artículo 101238- mai 2022 Regresar al número
Artículo precedente
- Carnosol inhibits the growth and biofilm of Candida albicans
- Longfei Yang, Yujie Sui, Lili Zhong, Tonghui Ma, Zhiming Ma, Xin Liu
- Effectiveness of a real-time PCR for diagnosis of Pneumocystis pneumonia in immunocompromised patients – Experience from a tertiary care center, India
- Dhanalakshmi S, Thambu David S, Richa Gupta, Santosh Varughese, George M Varghese, Biju George, Joy S Michael
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.